BLAU FARMACÊUTICA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.29 BRL | +20.65% |
|
+2.85% | -25.11% |
| May. 08 | Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 07 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Blau Farmacêutica S.A.
Price target over the last 5 years
History of analyst recommendation changes
16d323.pf_K8gYq7kRXY_dNEg7sDBmBTikpEaFhU_si-SlvqJM.xrC4uEUaoisOIJMBeE3UXF_zJ3BHWukFAoERrxw8_tbrkq-XYB-afR4ulA~8845023da4d43619997488131cd05d7e
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
12.29
BRL
Average target price
12.71
BRL
Spread / Average Target
+3.45%
High Price Target
18
BRL
Spread / Highest target
+46.46%
Low Price Target
11
BRL
Spread / Lowest Target
-10.50%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- BLAU3 Stock
- Consensus Blau Farmacêutica S.A.
